Scinai Immunotherapeutics (SCNI) Debt to Equity (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Debt to Equity for 2 consecutive years, with $0.04 as the latest value for Q4 2025.
- Quarterly Debt to Equity rose 39.23% to $0.04 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.04 through Dec 2025, up 39.23% year-over-year, with the annual reading at $0.04 for FY2025, 39.23% up from the prior year.
- Debt to Equity hit $0.04 in Q4 2025 for Scinai Immunotherapeutics, up from $0.03 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.04 in Q4 2025 to a low of $0.03 in Q4 2024.